Painreform Stock Market Value
| PRFX Stock | USD 0.69 0.02 2.82% |
| Symbol | Painreform |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Painreform. Anticipated expansion of Painreform directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Painreform assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Painreform using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Painreform's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Painreform's market price to deviate significantly from intrinsic value.
It's important to distinguish between Painreform's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Painreform should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Painreform's market price signifies the transaction level at which participants voluntarily complete trades.
Painreform 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Painreform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Painreform.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Painreform on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Painreform or generate 0.0% return on investment in Painreform over 90 days. Painreform is related to or competes with Universe Pharmaceuticals, Elevai Labs, Dermata Therapeutics, Psyence Biomedical, Avenue Therapeutics, Virax Biolabs, and NewcelX. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More
Painreform Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Painreform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Painreform upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 53.02 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 9.38 |
Painreform Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Painreform's standard deviation. In reality, there are many statistical measures that can use Painreform historical prices to predict the future Painreform's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.59) |
Painreform February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.58) | |||
| Mean Deviation | 5.01 | |||
| Coefficient Of Variation | (1,314) | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.12 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.59) | |||
| Maximum Drawdown | 53.02 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 9.38 | |||
| Skewness | 2.22 | |||
| Kurtosis | 10.21 |
Painreform Backtested Returns
Painreform maintains Sharpe Ratio (i.e., Efficiency) of -0.0761, which implies the firm had a -0.0761 % return per unit of risk over the last 3 months. Painreform exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Painreform's Variance of 57.12, coefficient of variation of (1,314), and Risk Adjusted Performance of (0.05) to confirm the risk estimate we provide. The company holds a Beta of 1.0, which implies possible diversification benefits within a given portfolio. Painreform returns are very sensitive to returns on the market. As the market goes up or down, Painreform is expected to follow. At this point, Painreform has a negative expected return of -0.58%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Painreform performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.34 |
Below average predictability
Painreform has below average predictability. Overlapping area represents the amount of predictability between Painreform time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Painreform price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Painreform price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.